首頁 產業/市場分類 出版商一覽 Email 通知 GII媒體代理會議 公司簡介 聯絡我們
- English Japanese Korean
首頁 > 市場調查報告書 > 醫療設備 > 心血管設備 > 全球心臟輔助裝置的市場(到2017年為止):心室輔助裝置和全人工心臟的普及伴隨的市場成長
產業/市場分類
醫療設備 (4528)
內視鏡檢查設備 (158)
分子呈像/呈影劑 (28)
心血管設備 (335)
可拋式醫學設備 (76)
核子醫學 (80)
病患監測 (382)
眼科設備 (102)
傷口護理 (159)
超音波 (54)
齒科設備 (174)
導管 (232)
整形外科 (335)
醫學影像診斷 (414)
體外診斷設備 (476)
CT/MRI/X光 (172)
e保健 (321)
市場調查報告書

全球心臟輔助裝置的市場(到2017年為止):心室輔助裝置和全人工心臟的普及伴隨的市場成長

Cardiac Assist Devices Market to 2017 - Increasing Uptake of Ventricular Assist Devices and Total Artificial Heart to Drive Growth

出版商 GBI Research
出版日期 2012年01月 商品編碼 227862
內容資訊 英文 Pages: 81
價格
US $ 3500 PDF by E-mail (Single user license)
US $ 7000 PDF by E-mail (Site license)
US $ 10500 PDF by E-mail (Global license)


全球心臟輔助裝置的市場(到2017年為止):心室輔助裝置和全人工心臟的普及伴隨的市場成長 是由出版商GBI Research在2012年01月所出版的。 這份英文市場調查報告書包含Pages: 81 價格從美金3500起跳。

簡介

本報告提供全球的心臟輔助裝置的市場相關分析,最新的技術·市場趨勢,及整體市場及主要國家·各部門的市場收益實際成果值(2003∼2010年)及預測值(2010∼2017年),再加上主要企業簡介,最新的產品趨勢,企業合作的實質等資訊彙整,為您概述為以下內容。

第1章 目錄

第2章 簡介

第3章 市場特徵

  • 收益實際成果值(2003∼2010年)
  • 收益預測值(2010∼2017年)
  • 主要的技術趨勢
    • 心臟輔助裝置的技術進步與全人工心臟的模式轉變
  • 市場動態
    • 推動市場要素
    • 阻礙市場要素
  • 主要企業的市場佔有率(2010年)

第4章 各分類分析與預測

  • 心室輔助裝置 (VAD)
    • 收益實際成果值(2003∼2010年)
    • 收益預測值(2010∼2017年)
    • 市場動態
  • 主動脈內氣球幫浦 (IABP)
    • 收益實際成果值(2003∼2010年)
    • 收益預測值(2010∼2017年)
    • 市場動態
  • 全人工心臟
    • 收益實際成果值(2003∼2010年)
    • 收益預測值(2010∼2017年)
    • 市場動態

第5章 各國市場分析與預測(2003∼2017年)

  • 各國市場收益預測(2003∼2017年)
    • 市場收益實際成果值·預測值:美國(2003∼2017年)
    • 市場收益實際成果值·預測值:加拿大(2003∼2017年)
    • 市場收益實際成果值·預測值:英國(2003∼2017年)
    • 市場收益實際成果值·預測值:德國(2003∼2017年)
    • 市場收益實際成果值·預測值:法國(2003∼2017年)
    • 市場收益實際成果值·預測值:義大利(2003∼2017年)
    • 市場收益實際成果值·預測值:西班牙(2003∼2017年)
    • 市場收益實際成果值·預測值:日本(2003∼2017年)
    • 市場收益實際成果值·預測值:中國(2003∼2017年)
    • 市場收益實際成果值·預測值:印度(2003∼2017年)
    • 市場收益實際成果值·預測值:澳洲(2003∼2017年)
    • 市場收益實際成果值·預測值:巴西(2003∼2017年)

第6章 競爭環境

  • Thoratec Corporation
  • MAQUET GmbH & Co. KG
  • Teleflex Incorporated
  • HeartWare International, Inc.
  • Berlin Heart GmbH
  • ABIOMED, Inc
  • SynCardia Systems, Inc

第7章 產品平台分析

  • 心室輔助裝置
    • 左心室用輔助設備
    • 外心室輔助設備
    • 兩心室輔助設備
    • 其他的設備
  • 主動脈內氣球幫浦
    • 經心臟幫浦
  • 全人工心臟
    • 50cc型全人工心臟
    • SmartHeart式全人工心臟
    • BiVACOR設備

第8章 企業整合環境

  • 交易數量(2005∼2010年)
  • 2011年的主要交易
  • 主要企業收購交易(2005∼2010年)
  • 主要的夥伴關係契約(2005∼20107年)

第9章 附錄

圖表一覽

目錄

Abstract

Scope

  • Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia and Brazil.
  • Market size data for two cardiac assist devices market categories - ventricular assist devices, Intra-aortic balloon pumps and total artificial heart
  • Annualized market revenues data, forecast forward for 7 years to 2017. Company shares data for 2010.
  • Qualitative analysis of key market trends for global cardiac assist devices market.
  • Qualitative analysis of market drivers and restraints by each category within the cardiac assist devices market.
  • The report also covers information on the leading market players, the competitive landscape, and the leading technologies.

Reasons to buy

  • Develop business strategies by understanding the trends and developments that are driving the cardiovascular devices market globally.
  • Design and develop your product development, marketing and sales strategies.
  • Exploit M&A opportunities by identifying market players with the most innovative pipeline.
  • Develop market-entry and market expansion strategies.
  • Identify key players best positioned to take advantage of the emerging market opportunities.
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
  • What's the next big thing in the cardiovascular devices market landscape? - Identify, understand and capitalize.
  • Make more informed business decisions from the insightful and in-depth analysis of the global cardiovascular devices market and the factors shaping it.

Executive Summary

GBI Research's report, “Cardiac Assist Devices Market to 2017 - Increasing Uptake of Ventricular Assist Devices and Total Artificial Heart to Drive Growth” provides key data, information and analysis on the global cardiac assist devices market. The report provides the market landscape, competitive landscape and market trends information of three cardiac assist devices market categories - Ventricular Assist Devices (VAD), Intra-Aortic Balloon Pumps (IABP) and Total Artificial Heart (TAH). The report also provides comprehensive information on the key trends that affect these categories, along with key analytical content concerning market dynamics. The report also reviews the competitive landscape by outlining the major acquisitions and mergers of the last seven years and providing a detailed analysis of pipeline products in each category. This report was created usng data and information sourced from proprietary databases, primary and secondary research, and in-house analysis by GBI Research's team of industry experts.

The Global Cardiac Assist Devices Market is Forecast to Reach $1.4 Billion in 2017

The global market for cardiac assist devices is forecast to exceed $1.4 billion by 2017, with a Compounded Annual Growth Rate (CAGR) of 8.6% from 2010 to 2017. The market is expected to be driven by increasing rates of cardiovascular diseases and the aging population. The shortage of donor hearts for transplantation is also leading to an increase in adoption of cardiac assist devices in patients with end-stage heart failure. Cardiac assist devices are also being used as a Bridge-To-Transplantation (BTT), bridge-to-recovery or destination therapy, depending on the requirement of the patient and the severity of the disease. Technological advancements that make the devices more efficient and minimally invasive are expected to further drive the demand for cardiac assist devices in the future.

The US is the Biggest Market for Cardiac Assist Devices

The US has the biggest market for cardiac assist devices, contributing about 55% of the global market share in 2010. This amounted to $437.4m in 2010. The cardiac assist devices market in the US is forecast to grow at a CAGR of 10.6% to reach a market value of $882.3m in 2017.

Factors such as longer lifespans, an increasing patient population, growing patient awareness, reimbursement coverage for cardiac assist device implantation procedures and higher availability due to the large number of heart care centers throughout the country, explain why the US has the biggest market for cardiac assist devices. Various pipeline products are undergoing clinical trials in the US in order to provide robust clinical data on the safety and efficacy of the devices. The launch and approval of novel technologically advanced products will further drive demand for cardiac assist devices in the future.

Thoratec Corporation was the Leading Company in the Global Cardiac Assist Devices Market in 2010

In 2010, the Thoratec Corporation, with a 48% share, was the leader in the global cardiac assist devices market. It was followed by MAQUET GmbH & Co. with a 17% share, and Teleflex Incorporated with a 7% market share. The other significant players in this market include HeartWare International, Berlin Heart GmbH, ABIOMED and SynCardia Systems. Thoratec Corporation and Berlin Heart are major players in the VAD segment. Companies such as MAQUET and Teleflex are major players in the IABP segment. SynCardia is the first company to offer the only Food and Drug Administration (FDA) approved TAH. There are a number of products in the pipeline currently undergoing clinical trials. The development of technologically advanced cardiac assist devices and the existence of extensive clinical studies has been predicted to drive the growth of the global cardiac assist devices market in the future.

Ventricular Assist Devices to Continue to be the Largest Segment in the Global Cardiac Assist Devices Market

The global VAD market accounted for 63% of the overall cardiac assist devices market and was valued at $500.3m in 2010 and is forecast to grow at a CAGR of 11.3% to reach a market value of $1,054.8m in 2017. The increasing risk of heart failure in the current population and shortage of donor hearts for transplantation has led to the market growth of the VAD segment. The devices are used in patients for destination therapy (long-term cardiac assist), as a BTT and as a bridge-to-recovery. VADs are also expected to become the second preferred treatment of heart failure after oral medications. Technological advancements that make the VADs more efficient and minimally invasive are expected to drive demand in the future. The extensive clinical studies being carried out on VADs are expected to increase the rate of physician adoption in the future, leading to the growth of the global VAD market.

Technological Advancements in Cardiac Assist Devices and Paradigm Shift Towards Total Artificial Heart

Cardiac assist devices have seen various technological advancements, leadingto an increase in their adoption by physicians and an increase in demand for better and more advanced products in the market. Physicians now prefer the TAH over VADs for the treatment of patients waiting for heart transplant. This paradigm shift in the field of cardiac assist devices is expected to drive the growth of the market in the future.

The technological developments in the IABP segment include improvement of timing technology and adaptation to various conditions and patient sizes. For instance, the SENSATION 7Fr. IABP Catheter by Maquet is the smallest IAB catheter with fiber-optic technology, making it easier for use in patients with smaller blood vessels.

There were also various technological advancements in VAD products that focused on minimizing risks and complications, and improving durability and efficiency by hemodynamic designing and miniaturization of the devices. For instance, the HeartAssist 5 VAD by MicroMed Cardiovascular is a fifth generation device and the world's lightest and smallest VAD. It is less invasive and offers treatment for a wide variety of patients from children to adults. In addition, it provides accurate measurement of blood flow as it uses an exclusive blood flow probe and pump. Hence there are various VAD products in the pipeline with better and more enhanced features and benefits. The market launch of these would help VAD- based treatment become a viable option for heart failure patients in the future.

However, for the treatment of patients requiring permanent cardiac support, the TAH can be a viable treatment option for destination therapy. The TAH by SynCardia Systems was the first to receive market approval in the cardiac assist devices market. These devices perform in a similarway to BIVADs, though various clinical studies have proved it to be a better option for destination therapy. This has led to a quicker adoption of the TAH and a paradigm shift in the preferences of physicians.

Table of Contents

1. Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2. Introduction

  • 2.1 GBI Research Guidance

3. Cardiac Assist Devices - Market Characterization

  • 3.1 Global Cardiac Assist Devices Market, Revenue ($m), 2003 - 2010
  • 3.2 Global Cardiac Assist Devices Market, Revenue Forecast ($m), 2010 - 2017
  • 3.3 Global Cardiac Assist Devices Market, Key Technology Trends
    • 3.3.1 Technological Advancements in Cardiac Assist Devices and Paradigm Shift Towards use of the Total Artificial Heart
  • 3.4 Global Cardiac Assist Devices, Market Dynamics
    • 3.4.1 Market Drivers
    • 3.4.2 Market Restraints
  • 3.5 Global Cardiac Assist Devices Market, Key Company Share (%), 2010

4. Global Cardiac Assist Devices Market - Category Analysis and Forecasts

  • 4.1 Ventricular Assist Devices (VADs)
    • 4.1.1 Ventricular Assist Devices Market, Global, Revenue ($m), 2003 - 2010
    • 4.1.2 Ventricular Assist Devices Market, Global, Revenue Forecast ($m), 2010 - 2017
    • 4.1.3 Ventricular Assist Devices, Market Dynamics
  • 4.2 Intra-Aortic Balloon Pumps (IABPs)
    • 4.2.1 Intra-Aortic Balloon Pumps Market, Global, Revenue ($m), 2003 - 2010
    • 4.2.2 Intra-Aortic Balloon Pumps Market, Global, Revenue Forecast ($m), 2010 - 2017
    • 4.2.3 Intra-Aortic Balloon Pumps - Market Dynamics
  • 4.3 Total Artificial Heart
    • 4.3.1 Total Artificial Heart Market, Global, Revenue ($m), 2003 - 2010
    • 4.3.2 Total Artificial Heart Market, Global, Revenue Forecast ($m), 2010 - 2017
    • 4.3.3 Total Artificial Heart - Market Dynamics

5. Global Cardiac Assist Devices Market - Country Analysis and Forecasts, 2003 - 2017

  • 5.1 Revenue Forecasts, by Country, 2003 - 2017
    • 5.1.1 Cardiac Assist Devices Market, US, Revenue ($m), 2003 - 2010
    • 5.1.2 Cardiac Assist Devices Market, US, Revenue ($m), 2010 - 2017
    • 5.1.3 Cardiac Assist Devices Market, Canada, Revenue ($m), 2003 - 2010
    • 5.1.4 Cardiac Assist Devices Market, Canada, Revenue ($m), 2010 - 2017
    • 5.1.5 Cardiac Assist Devices Market, UK, Revenue ($m), 2003 - 2010
    • 5.1.6 Cardiac Assist Devices Market, UK, Revenue ($m), 2010 - 2017
    • 5.1.7 Cardiac Assist Devices Market, Germany, Revenue ($m), 2003 - 2010
    • 5.1.8 Cardiac Assist Devices Market, Germany, Revenue ($m), 2010 - 2017
    • 5.1.9 Cardiac Assist Devices Market, France, Revenue ($m), 2003 - 2010
    • 5.1.10 Cardiac Assist Devices Market, France, Revenue ($m), 2010 - 2017
    • 5.1.11 Cardiac Assist Devices Market, Italy, Revenue ($m), 2003 - 2010
    • 5.1.12 Cardiac Assist Devices Market, Italy, Revenue ($m), 2010 - 2017
    • 5.1.13 Cardiac Assist Devices Market, Spain, Revenue ($m), 2003 - 2010
    • 5.1.14 Cardiac Assist Devices Market, Spain, Revenue ($m), 2010 - 2017
    • 5.1.15 Cardiac Assist Devices Market, Japan, Revenue ($m), 2003 - 2010
    • 5.1.16 Cardiac Assist Devices Market, Japan, Revenue ($m), 2010 - 2017
    • 5.1.17 Cardiac Assist Devices Market, China, Revenue ($m), 2003 - 2010
    • 5.1.18 Cardiac Assist Devices Market, China, Revenue ($m), 2010 - 2017
    • 5.1.19 Cardiac Assist Devices Market, India, Revenue ($m), 2003 - 2010
    • 5.1.20 Cardiac Assist Devices Market, India, Revenue ($m), 2010 - 2017
    • 5.1.21 Cardiac Assist Devices Market, Australia, Revenue ($m), 2003 - 2010
    • 5.1.22 Cardiac Assist Devices Market, Australia, Revenue ($m), 2010 - 2017
    • 5.1.23 Cardiac Assist Devices Market, Brazil, Revenue ($m), 2003 - 2010
    • 5.1.24 Cardiac Assist Devices Market, Brazil, Revenue ($m), 2010 - 2017

6. Global Cardiac Assist Devices Market - Competitive Assessment

  • 6.1 Thoratec Corporation
    • 6.1.1 Key Marketed Products
    • 6.1.2 SWOT Analysis
  • 6.2 MAQUET GmbH & Co. KG
    • 6.2.1 Key Marketed Products
    • 6.2.2 SWOT Analysis
  • 6.3 Teleflex Incorporated
    • 6.3.1 Key Marketed Products
    • 6.3.2 SWOT Analysis
  • 6.4 HeartWare International, Inc.
    • 6.4.1 Marketed Product
    • 6.4.2 SWOT Analysis
  • 6.5 Berlin Heart GmbH
    • 6.5.1 Key Marketed Products
    • 6.5.2 SWOT Analysis
  • 6.6 ABIOMED, Inc.
    • 6.6.1 Key Marketed Products
    • 6.6.2 SWOT Analysis
  • 6.7 SynCardia Systems, Inc.
    • 6.7.1 SWOT Analysis

7. Global Cardiac Assist Devices Market - Product Pipeline Analysis

  • 7.1 Ventricular Assist Devices
    • 7.1.1 Left Ventricular Assist Devices
    • 7.1.2 External Ventricular Assist Devices
    • 7.1.3 Biventricular Assist Devices
    • 7.1.4 Other Ventricular Assist Devices
  • 7.2 Intra-Aortic Balloon Pumps
    • 7.2.1 Percutaneous Heart Pump
  • 7.3 Total Artificial Heart
    • 7.3.1 50cc Total Artificial Heart
    • 7.3.2 SmartHeart Total Artificial Heart
    • 7.3.3 BiVACOR Device

8. Global Cardiac Assist Devices Market - Consolidation Landscape

  • 8.1 Cardiac Assist Devices Market, Number of Deals, Global, 2005 - 2010
  • 8.2 Key Deals of 2011
    • 8.2.1 Thoratec Acquires Medical Business of Levitronix
  • 8.3 Key Acquisition Deals, 2005 - 2010
    • 8.3.1 Asahi Kasei Acquires 60% Interest in Evaheart Medical
    • 8.3.2 Getinge Acquires Datascope
    • 8.3.3 ABIOMED Acquires Impella Cardiosystems
  • 8.4 Key Partnership Deals, 2005 - 2010
    • 8.4.1 9World Heart Signed Licensing Agreement with LaunchPoint Technologies and Carnegie Mellon University
    • 8.4.2 Thoratec Signed an Agreement with Levitronix

9. Appendix

  • 9.1 Definitions
    • 9.1.1 Cardiac Assist Devices
  • 9.2 Acronyms
  • 9.3 Research Methodology
    • 9.3.1 Secondary Research
    • 9.3.2 Primary Research
    • 9.3.3 Models
    • 9.3.4 Forecasts
    • 9.3.5 Expert Panels
  • 9.4 Contact Us
  • 9.5 Disclaimer
  • 9.6 Sources

List of Tables

  • Table 1: Cardiac Assist Devices Market, Global, Revenue ($m), 2003 - 2010
  • Table 2: Cardiac Assist Devices Market, Global, Revenue ($m), 2010 - 2017
  • Table 3: Ventricular Assist Devices, Advanced Technology Based Pipeline Products
  • Table 4: Incidence of Cardiovascular Disease (per 1000), US, 2008
  • Table 5: Population Aged 65 and Above (million), Global, 2004-2010
  • Table 6: Cardiac Assist Devices Market, Emerging Countries, Average Selling Price ($m), 2010
  • Table 7: Cardiac Assist Devices Market, Global, Key Company Revenues ($m), 2010
  • Table 8: Ventricular Assist Devices Market, Global, Revenue ($m), 2003 - 2010
  • Table 9: Ventricular Assist Devices Market, Global, Revenue ($m), 2010 - 2017
  • Table 10: Ventricular Assist Devices, Advanced Technology Based Pipeline Products
  • Table 11: Ventricular Assist Devices, Clinical Trials Evaluating Safety/Efficacy
  • Table 12: Intra-Aortic Balloon Pumps Market, Global, Revenue ($m), 2003 - 2010
  • Table 13: Intra-Aortic Balloon Pumps Market, Global, Revenue ($m), 2010 - 2017
  • Table 14: Intra-Aortic Balloon Pumps, No. of Procedures, (2006 - 2010)
  • Table 15: Intra-Aortic Balloon Pumps, No. of Procedures, (2010 - 2016)
  • Table 16: Total Artificial Heart Market, Global, Revenue ($m), 2003 - 2010
  • Table 17: Total Artificial Heart Market, Global, Revenue ($m), 2010 - 2017
  • Table 18: Cardiac Assist Devices Market, US, Revenue ($m), 2003 - 2010
  • Table 19: Cardiac Assist Devices Market, US, Revenue ($m), 2010 - 2017
  • Table 20: Cardiac Assist Devices Market, Canada, Revenue ($m), 2003 - 2010
  • Table 21: Cardiac Assist Devices Market, Canada, Revenue ($m), 2010 - 2017
  • Table 22: Cardiac Assist Devices Market, UK, Revenue ($m), 2003 - 2010
  • Table 23: Cardiac Assist Devices Market, UK, Revenue ($m), 2010 - 2017
  • Table 24: Cardiac Assist Devices Market, Germany, Revenue ($m), 2003 - 2010
  • Table 25: Cardiac Assist Devices Market, Germany, Revenue ($m), 2010 - 2017
  • Table 26: Cardiac Assist Devices Market, France, Revenue ($m), 2003 - 2010
  • Table 27: Cardiac Assist Devices Market, France, Revenue ($m), 2010 - 2017
  • Table 28: Cardiac Assist Devices Market, Italy, Revenue ($m), 2003 - 2010
  • Table 29: Cardiac Assist Devices Market, Italy, Revenue ($m), 2010 - 2017
  • Table 30: Cardiac Assist Devices Market, Spain, Revenue ($m), 2003 - 2010
  • Table 31: Cardiac Assist Devices Market, Spain, Revenue ($m), 2010 - 2017
  • Table 32: Cardiac Assist Devices Market, Japan, Revenue ($m), 2003 - 2010
  • Table 33: Cardiac Assist Devices Market, Japan, Revenue ($m), 2010 - 2017
  • Table 34: Cardiac Assist Devices Market, China, Revenue ($m), 2003 - 2010
  • Table 35: Cardiac Assist Devices Market, China, Revenue ($m), 2010 - 2017
  • Table 36: Cardiac Assist Devices Market, India, Revenue ($m), 2003 - 2010
  • Table 37: Cardiac Assist Devices Market, India, Revenue ($m), 2010 - 2017
  • Table 38: Cardiac Assist Devices Market, Australia, Revenue ($m), 2003 - 2010
  • Table 39: Cardiac Assist Devices Market, Australia, Revenue ($m), 2010 - 2017
  • Table 40: Cardiac Assist Devices Market, Brazil, Revenue ($m), 2003 - 2010
  • Table 41: Cardiac Assist Devices Market, Brazil, Revenue ($m), 2010 - 2017
  • Table 42: Thoratec Corporation, Cardiac Assist Devices, Key Marketed Products, 2010
  • Table 43: MAQUET GmbH, Key Products, Cardiac Assist Devices, Global, 2010
  • Table 44: Teleflex Incorporated, Key Products, Cardiac Assist Devices, Global, 2010
  • Table 45: ABIOMED, Inc., Key Products, Cardiac Assist Devices, Global, 2010
  • Table 46: Ventricular Assist Devices, Pipeline Assessment, by Development Stage
  • Table 47: Left Ventricular Assist Devices, Pipeline Products
  • Table 48: External Ventricular Assist Devices, Pipeline Products
  • Table 49: Biventricular Assist Devices, Pipeline Products
  • Table 50: Total Artificial Heart, Pipeline Products
  • Table 51: Cardiac Assist Devices Market, Number of Deals, Global, 2005 - 2010
  • Table 52: Cardiac Assist Devices Market, Number of Deals, Global, 2005 - 2010

List of Figures

  • Figure 1: Cardiac Assist Devices, Market Categorization and Segmentation
  • Figure 2: Cardiac Assist Devices Market, Global, Revenue ($m), 2003 - 2010
  • Figure 3: Cardiac Assist Devices Market, Global, Revenue ($m), 2010 - 2017
  • Figure 4: Cardiac Assist Devices, Market Dynamics
  • Figure 5: Incidence of Cardiovascular Disease (per 1000), US, 2008
  • Figure 6: Population Aged 65 and Above (million), Global, 2004-2010
  • Figure 7: Cardiac Assist Devices Market, Global, Company Share (%), 2010
  • Figure 8: Ventricular Assist Devices Market, Global, Revenue ($m), 2003 - 2010
  • Figure 9: Ventricular Assist Devices Market, Global, Revenue ($m), 2010 - 2017
  • Figure 10: Intra-Aortic Balloon Pumps Market, Global, Revenue ($m), 2003 - 2010
  • Figure 11: Intra-Aortic Balloon Pumps Market, Global, Revenue ($m), 2010 - 2017
  • Figure 12: Intra-Aortic Balloon Pumps, No. of Procedures, Global, (2006 - 2016)
  • Figure 13: Total Artificial Heart Market, Global, Revenue ($m), 2003 - 2010
  • Figure 14: Total Artificial Heart Market, Global, Revenue ($m), 2010 - 2017
  • Figure 15: Cardiac Assist Devices Market, US, Revenue ($m), 2003 - 2010
  • Figure 16: Cardiac Assist Devices Market, US, Revenue ($m), 2010 - 2017
  • Figure 17: Cardiac Assist Devices Market, Canada, Revenue ($m), 2003 - 2010
  • Figure 18: Cardiac Assist Devices Market, Canada, Revenue ($m), 2010 - 2017
  • Figure 19: Cardiac Assist Devices Market, UK, Revenue ($m), 2003 - 2010
  • Figure 20: Cardiac Assist Devices Market, UK, Revenue ($m), 2010 - 2017
  • Figure 21: Cardiac Assist Devices Market, Germany, Revenue ($m), 2003 - 2010
  • Figure 22: Cardiac Assist Devices Market, Germany, Revenue ($m), 2010 - 2017
  • Figure 23: Cardiac Assist Devices Market, France, Revenue ($m), 2003 - 2010
  • Figure 24: Cardiac Assist Devices Market, France, Revenue ($m), 2010 - 2017
  • Figure 25: Cardiac Assist Devices Market, Italy, Revenue ($m), 2003 - 2010
  • Figure 26: Cardiac Assist Devices Market, Italy, Revenue ($m), 2010 - 2017
  • Figure 27: Cardiac Assist Devices Market, Spain, Revenue ($m), 2003 - 2010
  • Figure 28: Cardiac Assist Devices Market, Spain, Revenue ($m), 2010 - 2017
  • Figure 29: Cardiac Assist Devices Market, Japan, Revenue ($m), 2003 - 2010
  • Figure 30: Cardiac Assist Devices Market, Japan, Revenue ($m), 2010 - 2017
  • Figure 31: Cardiac Assist Devices Market, China, Revenue ($m), 2003 - 2010
  • Figure 32: Cardiac Assist Devices Market, China, Revenue ($m), 2010 - 2017
  • Figure 33: Cardiac Assist Devices Market, India, Revenue ($m), 2003 - 2010
  • Figure 34: Cardiac Assist Devices Market, India, Revenue ($m), 2010 - 2017
  • Figure 35: Cardiac Assist Devices Market, Australia, Revenue ($m), 2003 - 2010
  • Figure 36: Cardiac Assist Devices Market, Australia, Revenue ($m), 2010 - 2017
  • Figure 37: Cardiac Assist Devices Market, Brazil, Revenue ($m), 2003 - 2010
  • Figure 38: Cardiac Assist Devices Market, Brazil, Revenue ($m), 2010 - 2017
  • Figure 39: Cardiac Assist Devices, Competitive Assessment, 2010
  • Figure 40: Thoratec Corporation, SWOT Analysis, Cardiac Assist Devices, Global, 2010
  • Figure 41: MAQUET GmbH, SWOT Analysis, Cardiac Assist Devices, Global, 2010
  • Figure 42: Teleflex Incorporated, SWOT Analysis, Cardiac Assist Devices, Global, 2010
  • Figure 43: HeartWare International, Inc., SWOT Analysis, Cardiac Assist Devices, Global, 2010
  • Figure 44: Berlin Heart GmbH, SWOT Analysis, Cardiac Assist Devices, Global, 2010
  • Figure 45: ABIOMED, Inc., SWOT Analysis, Cardiac Assist Devices, Global, 2010
  • Figure 46: SynCardia Systems, Inc., SWOT Analysis, Cardiac Assist Devices, Global, 2010
  • Figure 47: Cardiac Assist Devices, Pipeline Products, By Segment
  • Figure 48: Ventricular Assist Devices, Pipeline Assessment, by Development Stage
  • Figure 49: Cardiac Assist Devices Market, Number of Deals, Global, 2005 - 2010
Back to Top